首页|期刊导航|菌物学报|基于网络毒理学与机器学习整合分析揭示赭曲霉毒素A诱导胃癌的关键生物标志物及其免疫调控机制

基于网络毒理学与机器学习整合分析揭示赭曲霉毒素A诱导胃癌的关键生物标志物及其免疫调控机制OA

Integrated analysis of network toxicology,machine learning,and multi-dimensional bioinformatics reveals the toxicological mechanisms of ochratoxin A in gastric carcinogenesis

中文摘要英文摘要

胃癌是一种受多重因素影响的恶性肿瘤,其发生与环境风险因素密切相关.赭曲霉毒素 A(OTA)作为一种广泛存在的真菌毒素,已被列为潜在的人类致癌物.本研究系统揭示了OTA诱导胃癌的分子机制,首次通过整合网络毒理学、机器学习与孟德尔随机化分析,筛选并验证出 4 个关键致病基因(ESR1、GSK3β、MET、MMP2);并阐明了其通过扰乱激素信号、代谢稳态及免疫微环境的多通路协同致癌.其中 GSK3β 被首次在遗传学层面证实与胃癌存在因果关联.这组基因标志物在胃癌发生中起核心调控作用,具有显著的诊断潜力,为 OTA 相关胃癌的风险预警与靶向干预提供了新型生物标志物与理论依据.

Gastric cancer(GC)is a multifactorial malignancy closely linked to environmental risk factors.Ochratoxin A(OTA),a widely distributed mycotoxin,has been classified as a probable human carcinogen.This study systematically elucidates the molecular mechanisms underlying OTA-induced gastric carcinogenesis.For the first time,through an integrated approach combining network toxicology,machine learning,and Mendelian randomization analysis,four key pathogenic genes(ESR1,GSK3β,MET,and MMP2)were identified and validated.The research further clarifies how OTA disrupts hormone signaling,metabolic homeostasis,and the tumor immune microenvironment,thereby driving cancer development through multi-pathway synergy.Notably,GSK3β was genetically confirmed for the first time to have a causal relationship with gastric cancer.These gene markers play a central regulatory role in gastric carcinogenesis and demonstrate significant diagnostic potential,providing novel biomarkers and a theoretical foundation for risk prediction and targeted intervention in OTA-associated gastric cancer.

白薇;钱紫星;黄国栋;饶显俊;陈晓霄;杨洋;魏玮

北京中医药大学,北京 100102中国中医科学院望京医院,北京 100102中国中医科学院望京医院,北京 100102中国中医科学院望京医院,北京 100102广州中医药大学,广东 广州 510006中国中医科学院望京医院,北京 100102中国中医科学院望京医院,北京 100102

赭曲霉毒素A胃癌网络毒理学机器学习分子对接核心基因肿瘤微环境

ochratoxin Agastric cancernetwork toxicologymachine learningmolecular dockingcore genestumor microenvironment

《菌物学报》 2026 (4)

95-115,21

国家重点研发计划"中医药现代化"重点专项(2023YFC3503600)中国中医科学院望京医院高水平中医医院建设项目-中医药临床循证研究专项(WJYY-XZKT-2023-06) This work was supported by the National Key Research and Development Program of China"Modernization of Traditional Chinese Medicine"Key Project(2023YFC3503600)and the Wangjing Hospital,China Academy of Chinese Medical Sciences High-level Traditional Chinese Medicine Hospital Construction Project-Traditional Chinese Medicine Clinical Evidence-based Research Project(WJYY-XZKT-2023-06).

10.13346/j.mycosystema.250351

评论